Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

ACADIA Pharmaceuticals Inc. (ACAD)

25.7   -0.45 (-1.72%) 07-19 16:00
Open: 26.1 Pre. Close: 26.15
High: 26.1 Low: 25.55
Volume: 1,161,813 Market Cap: 3705M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 26.174 - 26.319 26.319 - 26.437
Low: 25.1 - 25.306 25.306 - 25.473
Close: 25.397 - 25.703 25.703 - 25.951

Technical analysis

as of: 2019-07-22 1:35:53 AM
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 30.85     One year: 32.41
Support: Support1: 24.25    Support2: 20.18
Resistance: Resistance1: 26.41    Resistance2: 27.75
Pivot: 26.72
Moving Average: MA(5): 26.08     MA(20): 26.50
MA(100): 25.92     MA(250): 21.53
MACD: MACD(12,26): 0.10     Signal(9): 0.28
Stochastic oscillator: %K(14,3): 25.86     %D(3): 34.36
RSI: RSI(14): 45.03
52-week: High: 28.67  Low: 12.77  Change(%): 52.6
Average Vol(K): 3-Month: 97933  10-Days: 84444

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
ACAD has closed above bottom band by 3.1%. Bollinger Bands are 33.8% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Mon, 15 Jul 2019 16:07:17 Z
Interesting ACAD Put And Call Options For July 19th

Wed, 03 Jul 2019 13:38:01 Z
JKK's Holdings Imply 14% Gain Potential

Mon, 03 Jun 2019 16:08:16 Z
First Week of September 20th Options Trading For Acadia Pharmaceuticals (ACAD)

Thu, 23 May 2019 15:08:07 Z
Interesting ACAD Put And Call Options For July 5th

Wed, 08 May 2019 20:58:33 Z
Why Acadia Pharmaceuticals Stock Slumped in April

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 144.17
Shares Float (M) 104.65
% Held by Insiders 0.30
% Held by Institutions 98.72
Shares Short (K) 12250
Shares Short P. Month (K)

Stock Financials

EPS -2.100
EPS Est. Current Year -2.550
EPS Est. Next Year -1.960
EPS Est. Next Quarter -0.630
Forward EPS -0.610
Book Value (p.s.) 2.900
PEG Ratio -0.42
Profit Margin -116.10
Operating Margin -117.81
Return on Assets (ttm) -41.1
Return on Equity (ttm) -76.4
Qtrly Rev. Growth 28.8
Gross Profit (p.s.) 0.127
Sales Per Share
EBITDA (p.s.) -1.923
Qtrly Earnings Growth
Operating Cash Flow (M) -186.41
Levered Free Cash Flow (M) -89.35

Stock Valuations

P/E -12.24
P/E Growth Ratio -0.02
P/BV 8.86
P/S 2047054720.00
P/CF -19.88

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.